DESCRIPTION (provided by applicant): Impact of aging on naive CD4 T cell function. We have made substantial progress in understanding age-related defects in naive CD4 T cell function, using murine T cell receptor transgenic (TCR Tg) models. We have found that decreased responsiveness to TCR stimulation in naive T cells from aged animals leads to reduced IL-2 production, proliferation and effector generation both in vitro and in vivo. In addition, memory T cells that are derived from naive CD4 T cells obtained from aged animals exhibit severe defects in proliferation, cytokine production and cognate helper function. It is quite likely that this defect contributes significantly to the reduction in vaccine efficacy observed in the elderly.
Our studies have also shown that we can enhance the response of naive CD4 T cells from aged mice in vitro by the addition of exogenous IL-2 and in vivo by the use of adjuvants that induce the production of inflammatory cytokines. We have shown that a combination of these cytokines (TNFalpha, IL-1, IL-6) induces enhanced IL-2 production by aged naive cells by increasing NFKappaB activation. This, in turn, enhances primary effector generation both in vitro and in vivo. These results are exciting since they indicate that these age-related defects may be overcome by the use of adjuvants that induce higher levels of these cytokines.
In this current proposal, we will continue our studies using similar experimental models. We hypothesize that the origin of the age-related defect in naive CD4 T cells is due to the fact that they are chronologically older compared to those found in younger animals. If naive T cells are chronologically older, there must be factors which regulate this. In Aim 1, we will examine the factors that may be involved in the regulation of CD4 lifespan, including other lymphocyte populations, thymic output and endogenous cytokines. In Aim 2, we will determine the effects of these age-related defects on the ability of naive CD4 T cells from aged mice to generate functional memory cells. Our overall goal is to determine what factors are involved in the genesis of age-related CD4 T cell defects, how they work, and the impact that they have on the generation of functional memory cells which are involved in protection from infectious disease.
Public Health Relevance Statement
Data not available.
NIH Spending Category
Aging
Project Terms
AdjuvantAffectAgeAgingAnimalsAntibodiesAntigensB-LymphocytesBiological AssayCD4 Positive T LymphocytesCell AgingCell CountCell physiologyCellsCommunicable DiseasesDefectDropsElderlyEnvironmentEnvironmental Risk FactorExhibitsExperimental ModelsGenerationsGoalsGrantHomeostasisImmunizationIn SituIn VitroIndividualInfectionInflammatoryInterleukin-1Interleukin-2Interleukin-6Interleukin-7LongevityLymphocyteMHC Class II GenesMemoryMemory B-LymphocyteMusOutputPeripheralPopulationProductionRegulationT memory cellT-Cell ReceptorT-LymphocyteThymus GlandTimeTransgenic ModelTransgenic OrganismsWorkYouthage effectage relatedagedbasecell agecytokinein vivojuvenile animalmemory CD4 T lymphocyteprogramsresearch studyresponsethymocytevaccine efficacy
No Sub Projects information available for 5R37AG025805-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R37AG025805-05
Patents
No Patents information available for 5R37AG025805-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R37AG025805-05
Clinical Studies
No Clinical Studies information available for 5R37AG025805-05
News and More
Related News Releases
No news release information available for 5R37AG025805-05
History
No Historical information available for 5R37AG025805-05
Similar Projects
No Similar Projects information available for 5R37AG025805-05